Evifacotrep

DB21510InvestigationalSmall molecule

Evifacotrep is a small molecule drug. The usage of the INN stem '-cotrep' in the name indicates that Evifacotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist. Evifacotrep... Evifacotrep has a monoisotopic molecular weight of 441.06 Da.

Formula / weight: C₁₈H₁₂ClF₄N₅O₂ · 441.77 g/mol (avg)

Resolves to

Compound

UNII7HN8B66GF1CAS2413739-88-3ChEMBLCHEMBL4752870

Structure

InChIKeyIQFZADSTVFSHDX-UHFFFAOYSA-NSMILESFC1=CC(=C(OC2=C3CCN(CC3=NC=N2)C2=C(Cl)C(=O)NN=C2)C=C1)C(F)(F)F

What you can answer from here — as of August 31, 2026

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Evifacotrep, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account